Showing results (921-930 of 5,274) with videos related to

Sort By:
Pageof 528
Oncology|December 19, 2008
Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance imagesTatsuo Inoue, Masatoshi Kudo, Kinuyo Hatanaka, et al.
Oncology|December 19, 2008
Magnetic resonance imaging of hepatocellular carcinomaMasayuki Kanematsu, Hiroshi Kondo, Satoshi Goshima, et al.
Oncology|December 19, 2008
Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD ScoreSatoshi Kitai, Masatoshi Kudo, Yasunori Minami, et al.
Oncology|December 19, 2008
Systemic chemotherapy of hepatocellular carcinoma--Korean experienceHan Chu Lee
Oncology|August 21, 2008
Multifocal Epstein-Barr virus-associated smooth muscle tumor in adults with AIDS: case report and review of the literatureS Gallien, B Zuber, M Polivka, et al.
Oncology|August 21, 2008
Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cellsYouquan Bu, Zhengmei Yang, Quanhai Li, et al.
Oncology|August 21, 2008
Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patientsEdwin Herrmann, Stefan Bierer, Joachim Gerss, et al.
Oncology|March 5, 2009
Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancerJoanna M Brell, Khalid Matin, Terry Evans, et al.
Oncology|March 6, 2009
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationChristos Christodoulou, Ioannis Kostopoulos, Haralabos P Kalofonos, et al.
Oncology|February 28, 2009
Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature reviewBrian H Kim, Thomas Bradley, Julia Tai, et al.
Pageof 528